Allosteric inhibition occurs when a molecule binds to an allosteric site on an enzyme, causing a conformational change that decreases the enzyme's activity. In contrast, allosteric activation involves a molecule binding to an allosteric site on an enzyme, leading to a conformational change that increases the enzyme's activity. Essentially, allosteric inhibition decreases enzyme activity, while allosteric activation increases enzyme activity. **

Allosteric inhibition is typically reversible, meaning that the inhibitor can bind to the allosteric site and block the activity of the enzyme, but can also dissociate from the site, allowing the enzyme to regain its activity. This is in contrast to irreversible inhibition, where the inhibitor forms a covalent bond with the enzyme, permanently inactivating it. **

Allosteric inhibition is a type of enzyme regulation where a molecule binds to a site on the enzyme that is different from the active site, causing a conformational change in the enzyme's structure. This change reduces the enzyme's activity and ability to bind to its substrate, ultimately inhibiting its function. Allosteric inhibition is a reversible process and can be used to regulate enzyme activity in response to changing cellular conditions. **

Yes, Vmax can change in allosteric inhibition. Allosteric inhibition occurs when a molecule binds to an enzyme at a site other than the active site, causing a conformational change that reduces the enzyme's activity. This can result in a decrease in the enzyme's maximum velocity (Vmax) as the enzyme becomes less efficient at catalyzing the reaction. Therefore, allosteric inhibition can lead to a decrease in Vmax, ultimately affecting the rate of the enzymatic reaction. **

A cofactor allosteric activator is a molecule that binds to an enzyme at a site other than the active site, causing a conformational change in the enzyme that increases its activity. This type of activator works by promoting the enzyme's ability to bind to its substrate and carry out its catalytic function. Cofactor allosteric activators are important for regulating enzyme activity in response to changes in the cell's environment, allowing for fine-tuning of metabolic pathways and other cellular processes. **

End product repression is not automatically an allosteric inhibition. While end product repression often involves the inhibition of an enzyme by the end product of a metabolic pathway, this inhibition can occur through various mechanisms. Allosteric inhibition is one possible mechanism, where the end product binds to a site on the enzyme other than the active site, leading to a conformational change that inhibits the enzyme's activity. However, end product repression can also occur through competitive inhibition, non-competitive inhibition, or other regulatory mechanisms that do not involve allosteric binding. **

No, an end-product repression is not automatically an allosteric inhibition. End-product repression refers to the regulation of enzyme activity by the final product of a metabolic pathway, typically through feedback inhibition. This can occur through various mechanisms, including competitive inhibition or non-competitive inhibition, in addition to allosteric inhibition. Allosteric inhibition specifically involves the binding of a molecule at a site other than the active site, leading to a conformational change that affects enzyme activity. **

Competitive inhibition occurs when a molecule competes with the substrate for the active site of an enzyme, blocking the substrate from binding and inhibiting the enzyme's activity. In contrast, allosteric inhibition involves a molecule binding to a site on the enzyme that is not the active site, causing a conformational change in the enzyme that reduces its activity. Allosteric inhibitors can either enhance or reduce the enzyme's activity, depending on the specific molecule and its binding site on the enzyme. **